Elevara Medicines
PrivateLast Round
Series A
Oct 22, 2025
Total Funding Raised
$140M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Elevara Medicines is a clinical-stage biotechnology company developing novel therapeutics to treat rheumatoid arthritis and other chronic inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elevara Medicines Comparables
Compare Elevara Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astellas Pharma Inc. | 74% | |
| Revolo Biotherapeutics | 70% | |
| LAPIX Therapeutics | 69% | |
Elevara Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 22, 2025 | ||||
| Series A | Sep 1, 2025 | ||||
| Seed | Mar 1, 2025 |
Key People
Founding team and executive leadership
Elevara Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A |
| Monograph Capital | Series A, Seed |
| Sofinnova Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 51% MoM.
- Apr 3, 2026
Monthly visitors grew 64% MoM, from 586 to 959.
Elevara Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elevara Medicines's valuation, stock price, and market status.